Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGULUS-THERAPEUTICS-INC-46475580/news/Regulus-Therapeutics-Announces-First-Subject-Dosed-in-Phase-1-Single-Ascending-Dose-SAD-Clinical-T-40708617/?utm_source=whatsapp&utm_medium=social&utm_campaign=share